These days, you come across the term Full Spectrum everywhere when it comes to cannabis oil. But what does that term actually mean? And perhaps more importantly: does a product sold as Full Spectrum actually contain the broad spectrum of natural plant compounds that are naturally present in the cannabis plant?

According to Peter Vermeul, founder and owner of CBD Spain, this is still too easily overlooked in the cannabis world. Many products are judged primarily on their CBD and THC content. But according to him, that means you are only looking at a small part of what the cannabis plant naturally has to offer.

The plant contains a much greater variety of compounds. In addition to cannabinoids, such as CBDa, CBGa and THCa, there are terpenes, flavonoids, cannabflavones and sterols, among others. For Peter, it is precisely the combination and interaction of these plant compounds that form the essence of a truly Full Spectrum cannabis extract.

In his recent article What a truly Full-Spectrum Cannabis Extract means to me, he delves deeper into this subject. The occasion was a scientific study in which researchers compared different cannabis flowers and commercial cannabis extracts. The results show that the way cannabis is processed can have a major impact on the final composition of the extract.

A cancer diagnosis turns life completely upside down. And even after treatment is over, that doesn't automatically mean someone will feel well again. Pain, fatigue, sleep problems, loss of appetite, and mental distress can persist for a long time. For many people, this is precisely when they begin a search for additional options to support their health and quality of life.

Cannabis and cannabinoids are receiving increasing attention in this regard. But what do people actually use when they say they use cannabis? And does it make a difference whether someone takes an isolated cannabinoid or a full plant extract in which various natural components have been preserved?

Peter Vermeul, founder and owner of CBD Spain, delved into an interesting scientific study from 2026. His findings shed new light on cannabis use after cancer and, above all, on why it is important to look beyond the name cannabis alone.

From epileptic seizures and skin problems to a good old age. Garfield is now 17 years old and his story shows why Annette de Vogel looks at the whole picture when supporting animals and what role full-spectrum CBDa oil can play when a cat has epileptic seizures.

What if we didn't view cannabis as a collection of individual substances, but as a complete plant? And what happens when you keep that plant as intact as possible and choose a different method of administration?

These are questions that have preoccupied Peter Vermeul for years. As a pioneer and owner of CBD Spain, he delves not only into the cannabis plant itself, but especially into what is preserved during the production process. His starting point is simple, yet far-reaching: perhaps the value of a plant extract is not determined solely by how much CBD or THC it contains, but rather by the whole of the substances and their natural relationship to one another.

In his latest article, Peter describes his personal quest to understand the effects of full-plant extracts in the form of suppositories. A quest that did not begin with theoretical laboratory research, but with people. People with pain, sleep problems, nausea, anxiety, or a severely diminished quality of life.

And it was precisely there that the question arose for him: are we actually looking at the whole plant?

When we talk about cannabis and health, the conversation quickly turns to CBD and THC. But the cannabis plant is far more complex than these two well-known cannabinoids. It is precisely the lesser-known compounds that may have surprising biological properties.

This is once again evident in research into CBD and cannabidivarin (CBDV). In his article ‘CBDV against biofilms – An important step in cannabis research’, Peter Vermeul, founder and owner of CBD Spain, discusses research into the antifungal properties of various phytocannabinoids. CBDV, in particular, stands out.

For Peter, this research is interesting for a broader reason. In his view, it shows why it is worth looking not only at individual cannabinoids but also at the cannabis plant as a whole.

And this brings us to a topic that is central to his vision and to how we at CBD & Herb view CBD Spain oil: the power of a full-spectrum extract does not necessarily lie in a single individual compound, but in the natural synergy of many plant components.

Alzheimer's disease is one of the most devastating neurodegenerative disorders. As the disease progresses, memory and cognitive functions decline, and behavioral changes and restlessness may also occur. In the brain, the accumulation of amyloid-beta proteins and abnormalities in the tau protein play an important role, among others.

Despite the enormous amount of research, there is still no treatment that can cure Alzheimer's. That is precisely why it is interesting that in recent years, scientists have been increasingly looking at a system that is already naturally present in our body: the endocannabinoid system (ECS).

In his recent article 'Cannabis opens new doors in Alzheimer's', Peter Vermeul explores what the current scientific literature tells us about this. In doing so, he does not only look at CBD or THC as individual substances, but precisely at the broader whole of cannabinoids, cannabinoid acids, terpenes, flavonoids, and sterols that occur together in a Full Spectrum cannabis extract.

And that broader perspective is precisely what makes the research particularly interesting.

Sometimes a scientific discovery does not begin in a laboratory, but with one person. A story that makes you think. An experience that challenges existing insights and raises new research questions.

This is also how the story of Peter Vermeul began, founder of CBD Spain and developer of the plant-identical Full Spectrum CBDa extracts that we at CBD & Herb work with daily. Not from the question of which cannabinoid is the strongest, but from a much more fundamental question:

Does it matter which cannabis plant an extract comes from? And perhaps even more importantly: is the complete natural composition of that plant preserved during extraction?

Mitchell's story gave these questions momentum.

Can a plant influence processes involved in the development of cancer? It is a question that is being investigated more and more frequently. Not because cannabis is a miracle cure, but because scientists are increasingly understanding how the endocannabinoid system plays a role in inflammation, cell growth, immune responses, and the body's natural healing ability.

A recent scientific review, discussed by Peter Vermeul, owner and founder of CBD Spain, brings together the results of multiple studies on cannabinoids in experimental models of colon cancer. The findings are interesting and show why a full spectrum cannabis extract in particular receives so much attention within science.

Obstructive sleep apnea is much more than loud snoring or a restless night. It is a condition in which breathing repeatedly stops or becomes shallow during sleep. This causes oxygen levels in the body to drop, deep sleep to be constantly interrupted, and the body to have insufficient opportunity to truly recover. As a result, many people wake up feeling tired, experience concentration problems, and face an increased long-term risk of conditions such as cardiovascular disease.

Scientists are increasingly investigating whether cannabis can play a supportive role in managing this condition. A recent report from the Minnesota Medical Cannabis Program, which followed thousands of patients with obstructive sleep apnea, offers interesting insights. But according to researcher Peter Vermeul, owner of CBD Spain, this research also highlights where current science still falls short.

The world of cannabinoids is not standing still. Almost every week, new studies are published in which scientists search for ways to further improve the effectiveness of cannabinoids. One of the most discussed developments at the moment is exosomal cannabidiol (CBD). An innovative technique in which CBD is packaged in microscopically small natural transport vesicles, so that it can potentially be absorbed better by the body.

It sounds promising. But according to researcher Peter Vermeul, founder of CBD Spain, this development raises one major question above all:

Why is almost all research focused on CBD, when CBDa may actually be much more biologically interesting?

In his latest scientific article, Peter takes you on a journey through this fascinating development and shows why the future of cannabinoids may not lie in even more advanced techniques for CBD, but rather in the original cannabinoid acids that the cannabis plant itself produces.          

For years, medicinal cannabis was primarily seen as a means to alleviate symptoms such as pain, nausea, and loss of appetite. But science is developing at lightning speed. More and more research shows that cannabis is far more complex than was long thought. Not only because of the well-known cannabinoids such as CBD and THC, but precisely because of the unique interaction between dozens of other natural plant compounds.

A recent extensive scientific analysis confirms this development. More than 10,000 scientific publications were examined to find an answer to an important question: what does the entire body of scientific literature show about medicinal cannabis in cancer?

The result is striking. Not because cannabis is suddenly being presented as a miracle cure, but because the scientific consensus appears clearly more positive than the public debate often suggests.

In the world of cannabinoids, attention is often focused on well-known names such as CBD and THC. But those who look more closely at the cannabis plant discover a much more complex and fascinating story. A story in which no single substance takes center stage, but rather the natural synergy of hundreds of bioactive compounds.

According to Peter Vermeul, founder of CBD Spain and a pioneer in the field of organic full-spectrum cannabinoid extracts, this is precisely where the future of cannabis as a health product lies. Not in isolating a single active substance, but in understanding and preserving the plant's natural intelligence.

One of the most fascinating examples of this is a THCa full-spectrum extract with a rich varin profile.